(Q44599736)

English

Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes

scientific article published on October 1, 2003

Statements

Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes (English)
Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes (English)
1 October 2003
2835-2841

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit